{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:56:06Z","timestamp":1794293766072,"version":"4.9.0"},"reference-count":41,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2022,10,19]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Multimorbidity, the coexistence of two or more chronic conditions, has been extensively studied in certain disease states. Bronchiectasis aetiology is complex and multimorbidity is insufficiently understood. We performed a scoping review, summarising the existing literature and identifying deficits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A literature search of the electronic databases PubMed, CINAHL and EMBASE was conducted following PRISMA guidelines. Observational, interventional, qualitative, randomised control trials and systematic reviews were included. The main objective was to identify prevalence, prognosis, symptoms, quality of life and management in bronchiectasis multimorbidity. Key findings were analysed descriptively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>40 studies (200\u2005567 patients) met the inclusion criteria, the majority (68%) being cohort studies. Study size ranged from 25 to 57\u2005576 patients, with mean age 30\u201369\u2005years. 70% of studies investigated the prognosis of comorbidities and 68% prevalence; 70% analysed multiple comorbidities in bronchiectasis. The most frequent comorbid diseases evaluated were COPD (58%), cardiovascular disease (53%) and asthma (40%). COPD and hypertension were the most prevalent conditions (pooled mean 35% and 34% respectively). Multimorbidity was associated with increased mortality, exacerbations and hospitalisation rates. It had a negative impact on lung function. Mortality increased in the following comorbidities: COPD, gastro-oesophageal reflux disease and rheumatoid arthritis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Bronchiectasis multimorbidity is common. Research focuses on a few key aspects and favoured comorbidities (<jats:italic>e.g.<\/jats:italic>COPD). There is a deficit of research into symptoms, quality of life, interactions and management. High-resolution computed tomography diagnosis is not consistent, and there is no agreed multimorbidity screening questionnaire. Bronchiectasis multimorbidity is of importance; it is associated with morbidity and mortality.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00296-2022","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T09:52:12Z","timestamp":1673862732000},"page":"00296-2022","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Multimorbidity in bronchiectasis: a systematic scoping review"],"prefix":"10.1183","volume":"9","author":[{"given":"Imogen","family":"Marsland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-9244","authenticated-orcid":false,"given":"Ruth","family":"Sobala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-0344","authenticated-orcid":false,"given":"Anthony","family":"De Soyza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"2024101710040332000_9.1.00296-2022.1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2024101710040332000_9.1.00296-2022.2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/resp.12832","article-title":"Aetiology of bronchiectasis in adults: a systematic literature review","volume":"21","author":"Gao","year":"2016","journal-title":"Respirology"},{"key":"2024101710040332000_9.1.00296-2022.3","first-page":"6","article-title":"Inflammation: a two-edged sword \u2013 the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"2024101710040332000_9.1.00296-2022.4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2019"},{"key":"2024101710040332000_9.1.00296-2022.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201301-0059CI"},{"key":"2024101710040332000_9.1.00296-2022.6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaip.2016.08.005","article-title":"Lung disease in primary antibody deficiencies","volume":"4","author":"Schussler","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024101710040332000_9.1.00296-2022.7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4291\/wjgp.v5.i4.560","article-title":"Patterns of airway involvement in inflammatory bowel diseases","volume":"5","author":"Papanikolaou","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"2024101710040332000_9.1.00296-2022.8","first-page":"89","article-title":"Pulmonary involvement in rheumatoid arthritis: another face of the coin","volume":"53","author":"Iftimie","year":"2018","journal-title":"Arch Balk Med Union"},{"key":"2024101710040332000_9.1.00296-2022.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01567-2015"},{"key":"2024101710040332000_9.1.00296-2022.10","unstructured":"European Commission . Rare diseases. https:\/\/health.ec.europa.eu\/non-communicable-diseases\/steering-group\/rare-diseases_en Date last accessed: 21 November 2022."},{"key":"2024101710040332000_9.1.00296-2022.11","unstructured":"Orphanet Report Series . Rare Disease Registries in Europe. www.orpha.net\/orphacom\/cahiers\/docs\/GB\/Registries.pdf Date last accessed: February 2022. Date last updated: December 2021."},{"key":"2024101710040332000_9.1.00296-2022.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00954-2015"},{"key":"2024101710040332000_9.1.00296-2022.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01033-2015"},{"key":"2024101710040332000_9.1.00296-2022.14","unstructured":"Bronchiectasis Toolbox. Bronchiectasis Severity Index . 2015. https:\/\/bronchiectasis.com.au\/assessment\/medical\/bronchiectasis-severity-index Date last accessed: 10 March 2020."},{"key":"2024101710040332000_9.1.00296-2022.15","unstructured":"National Cancer Institute. NCI Comorbidity Index Overview . 2014. https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/considerations\/comorbidity.html Date last accessed: 10 March 2021."},{"key":"2024101710040332000_9.1.00296-2022.16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024101710040332000_9.1.00296-2022.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cky098"},{"key":"2024101710040332000_9.1.00296-2022.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010119"},{"key":"2024101710040332000_9.1.00296-2022.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012265"},{"key":"2024101710040332000_9.1.00296-2022.20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","article-title":"Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study","volume":"151","author":"De Soyza","year":"2017","journal-title":"Chest"},{"key":"2024101710040332000_9.1.00296-2022.21","doi-asserted-by":"crossref","first-page":"e0177931","DOI":"10.1371\/journal.pone.0177931","article-title":"Clinical impact of chronic obstructive pulmonary disease on noncystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry","volume":"12","author":"De la Rosa","year":"2017","journal-title":"PLoS One"},{"key":"2024101710040332000_9.1.00296-2022.22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12931-017-0659-x","article-title":"Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study","volume":"18","author":"Men\u00e9ndez","year":"2017","journal-title":"Respir Res"},{"key":"2024101710040332000_9.1.00296-2022.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01862-2015"},{"key":"2024101710040332000_9.1.00296-2022.24","first-page":"366","article-title":"Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype","volume":"46","author":"McDonnell","year":"2015","journal-title":"Eur Respir J"},{"key":"2024101710040332000_9.1.00296-2022.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.12.015"},{"key":"2024101710040332000_9.1.00296-2022.26","doi-asserted-by":"crossref","first-page":"1479973119839961","DOI":"10.1177\/1479973119839961","article-title":"Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice","volume":"16","author":"Seifer","year":"2019","journal-title":"Chron Respir Dis"},{"key":"2024101710040332000_9.1.00296-2022.27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/resp.12182","article-title":"Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis","volume":"19","author":"Lee","year":"2014","journal-title":"Respirology"},{"key":"2024101710040332000_9.1.00296-2022.28","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/crj.12432","article-title":"Emphysema is an independent risk factor for 5-year mortality in patients with bronchiectasis","volume":"11","author":"Tang","year":"2017","journal-title":"Clin Respir J"},{"key":"2024101710040332000_9.1.00296-2022.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.6.689"},{"key":"2024101710040332000_9.1.00296-2022.30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.genhosppsych.2014.01.010","article-title":"Mediterranean diet is associated on symptoms of depression and anxiety in patients with bronchiectasis","volume":"36","author":"Olveira","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"2024101710040332000_9.1.00296-2022.31","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12522"},{"key":"2024101710040332000_9.1.00296-2022.32","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.93.05040418"},{"key":"2024101710040332000_9.1.00296-2022.33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rmed.2019.06.010","article-title":"Extrapulmonary associations of health status in severe asthma and bronchiectasis: comorbidities and functional outcomes","volume":"154","author":"Cordova-Rivera","year":"2019","journal-title":"Respir Med"},{"key":"2024101710040332000_9.1.00296-2022.34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.arbres.2013.01.012","article-title":"Presence of anxiety and depression in patients with bronchiectasis unrelated to cystic fibrosis","volume":"49","author":"Gir\u00f3n Moreno","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"2024101710040332000_9.1.00296-2022.35","first-page":"S15","article-title":"Managing urinary incontinence in adults with bronchiectasis","volume":"22","author":"Rees","year":"2013","journal-title":"Br J Nurs"},{"key":"2024101710040332000_9.1.00296-2022.36","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.21037\/atm-20-4873","article-title":"Factors associated with bronchiectasis in Korea: a national database study","volume":"8","author":"Yang","year":"2020","journal-title":"Ann Transl Med"},{"key":"2024101710040332000_9.1.00296-2022.37","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1513\/AnnalsATS.201510-678OC","article-title":"The multiple faces of non-cystic fibrosis bronchiectasis. A cluster analysis approach","volume":"13","author":"Mart\u00ednez-Garc\u00eda","year":"2016","journal-title":"Ann Aum Thorac Soc"},{"key":"2024101710040332000_9.1.00296-2022.38","unstructured":"British Lung Foundation. Chronic Obstructive Pulmonary Disease (COPD) Statistics. 2022. https:\/\/statistics.blf.org.uk\/copd Date last accessed: 5 October 2022."},{"key":"2024101710040332000_9.1.00296-2022.39","doi-asserted-by":"crossref","unstructured":"Ferri S , Crimi C , Campisi R , et al. Impact of asthma on bronchiectasis severity and risk of exacerbations. J Asthma 2022; 59: 469\u2013475. doi: 10.1080\/02770903.2020.1857395","DOI":"10.1080\/02770903.2020.1857395"},{"key":"2024101710040332000_9.1.00296-2022.40","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3906\/sag-1511-137","article-title":"The factors affecting survival in patients with bronchiectasis","volume":"46","author":"\u00c7ift\u00e7i","year":"2016","journal-title":"Turk J Med Sci"},{"key":"2024101710040332000_9.1.00296-2022.41","doi-asserted-by":"crossref","unstructured":"McDonnell MJ , Ward C , Rutherford RM . Comorbidities and their impact. In: Chalmers JD, Polverino E, Aliberti S, eds. Bronchiectasis (ERS Monograph). Sheffield, European Respiratory Society, 2018; pp. 45\u201361. DOI: 10.1183\/2312508X.10015417","DOI":"10.1183\/2312508X.10015417"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00296-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:22:55Z","timestamp":1740374575000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00296-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,16]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1183\/23120541.00296-2022"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00296-2022","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1183\/23120541.00296-2022.supp1","asserted-by":"subject"}]},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}